Impact Biomedical (IBO) Notes Payables (2022 - 2025)

Impact Biomedical's Notes Payables history runs 4 years deep, the most recent figure standing at $22.9 million for Q3 2025.

• Quarterly Notes Payables rose 65274.29% year-over-year to $22.9 million in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $22.9 million (up 65274.29% YoY) and the FY2024 annual result came in at $8.9 million, down 26.47% from the prior year.
• Notes Payables was $22.9 million for Q3 2025 at Impact Biomedical, up from $22.4 million in the prior quarter.
• Across five years, Notes Payables topped out at $22.9 million in Q3 2025 and bottomed at $35000.0 in Q3 2024.
• A 4-year average of $12.3 million and a median of $11.8 million in 2023 frame the typical range for Notes Payables.
• Annual changes were most pronounced in 2024 — Notes Payables slumped 99.7% — and 2025, when it surged 65274.29%.
• Impact Biomedical's Notes Payables stood at $10.0 million in 2022, then gained by 20.85% to $12.1 million in 2023, then decreased by 26.47% to $8.9 million in 2024, then surged by 157.73% to $22.9 million in 2025.
• Business Quant data shows IBO's Notes Payables at $22.9 million in Q3 2025, $22.4 million in Q2 2025, and $9.1 million in Q1 2025.